As of August 2026 Protagonist Therapeutics has a market cap of NZ$17.30 Billion. This makes Protagonist Therapeutics the world's 2058th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Aug 18th, 2026 the market cap of Protagonist Therapeutics was reported to be: